Home > News > BioSante Pharmaceuticals Presents CaP Nanotechnology Review
May 18th, 2005
BioSante Pharmaceuticals Presents CaP Nanotechnology Review
Abstract:
BioSante Pharmaceuticals today announced that Dr. Steve Bell, vice president of research and pre-clinical development for BioSante, will present a review of progress with BioVant(TM), the company's patented calcium phosphate (CaP) nanoparticle technology, at the Second International Conference on Immunopotentiators in Modern Vaccines (IMV 2005) meeting in Malaga, Spain.
Source:
businesswire
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||